Found: 7
Select item for more details and to access through your institution.
Inactivation of RB1, CDKN2A, and TP53 have distinct effects on genomic stability at side‐by‐side comparison in karyotypically normal cells.
- Published in:
- Genes, Chromosomes & Cancer, 2023, v. 62, n. 2, p. 93, doi. 10.1002/gcc.23096
- By:
- Publication type:
- Article
Genetic profiling of a chondroblastoma‐like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1‐FGFR1 gene fusion.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 10, p. 731, doi. 10.1002/gcc.22764
- By:
- Publication type:
- Article
Loss of NF2 defines a genetic subgroup of non‐FOS‐rearranged osteoblastoma.
- Published in:
- Journal of Pathology: Clinical Research, 2020, v. 6, n. 4, p. 231, doi. 10.1002/cjp2.172
- By:
- Publication type:
- Article
NTRK fusions in osteosarcoma are rare and non‐functional events.
- Published in:
- Journal of Pathology: Clinical Research, 2020, v. 6, n. 2, p. 107, doi. 10.1002/cjp2.158
- By:
- Publication type:
- Article
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway.
- Published in:
- Journal of Pathology, 2024, v. 262, n. 2, p. 147, doi. 10.1002/path.6219
- By:
- Publication type:
- Article
Loss of the tumour suppressor gene AIP mediates the browning of human brown fat tumours.
- Published in:
- Journal of Pathology, 2017, v. 243, n. 2, p. 160, doi. 10.1002/path.4945
- By:
- Publication type:
- Article
Clonal competition within complex evolutionary hierarchies shapes AML over time.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-14106-0
- By:
- Publication type:
- Article